Bergisch-Gladbach, Germany

Pol Balmelis

This inventor holds 1 USPTO granted patent. Top assignee: Bayer Aktiengesellschaft. Active years: 1988.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1988

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Pol Balmelis: Innovator in Chemical Processes

Introduction

Pol Balmelis is a notable inventor based in Bergisch-Gladbach, Germany. He has made significant contributions to the field of chemistry, particularly in the processing of tar-like residues. His innovative approach has led to the development of a unique patent that addresses the challenges associated with these materials.

Latest Patents

Pol Balmelis holds a patent titled "Process for working up tars containing 2-mercaptobenzothiazole." This patent describes a method for utilizing tar-like residues from the preparation of 2-mercaptobenzothiazole. The process involves heating these residues at temperatures above 200 degrees Celsius for at least one hour, which allows for the separation of aniline and benzothiazole.

Career Highlights

Pol Balmelis is associated with Bayer Aktiengesellschaft, a leading global company in the pharmaceutical and life sciences sector. His work at Bayer has allowed him to focus on innovative chemical processes that contribute to the company's research and development efforts.

Collaborations

Throughout his career, Pol has collaborated with esteemed colleagues such as Guido Lahousse and Gabriel Denecker. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Pol Balmelis is a distinguished inventor whose work in chemical processes has led to valuable advancements in the industry. His patent on the processing of tar-like residues showcases his commitment to innovation and problem-solving in chemistry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…